At the outset, we have explored miR‐651‐5p and CALM2 expression in lung cancer tissues and cells and the connection between clinicopathological characteristics and poorer prognosis of patients with lung cancer with miR‐651‐5p expression. This evidence concerns the gene CALM2 and lung carcinoma.